Biolase (BIOL) – Press Releases
-
Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024
-
BIOLASE to Report Fourth Quarter and Full Year 2023 Results on March 21, 2024
-
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
-
Biolase Announces First Quarter 2024 Webinar Series 'Lets Talk Dental'
-
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering
-
BIOLASE, Inc. Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
-
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
-
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024
-
BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023
-
BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
-
BIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
-
BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial
-
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
BIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY BENEFITTING FROM STRATEGIC ACTIONS TAKEN TO STREAMLINE OPERATIONS AND GAIN GREATER OPERATIONAL EFFICIENCIES
-
Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio Protocol
-
BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023
-
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
-
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
-
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
-
BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
-
BIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023
-
BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT
-
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
-
BIOLASE EPIC HYGIENE DENTAL LASER RECEIVES PRESTIGIOUS CELLERANT BEST OF CLASS HYGIENE AWARD
-
BIOLASE Announces Grand Opening of Training Facility to Reach Wider Universe of Dental Practitioners; First-Hand Experience Using Leading Dental Laser Technology Expected to Generate Increased Revenue
-
BIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2023 VIRTUAL HEALTHCARE CONFERENCE HOSTED BY M-VEST ON JUNE 20TH - 22ND
-
BIOLASE INTEGRATES DIODE LASER TECHNOLOGY WITH PET DENTAL SERVICES
-
BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK
-
BIOLASE Takes Steps to Improve Operating Efficiency as the Company Pursues Sales and Profitability Goals
-
BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
-
BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023
-
BIOLASE TO REPORT FIRST QUARTER 2023 RESULTS ON MAY 11, 2023
-
BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023
-
BIOLASE GATHERS KEY OPINION LEADERS AND DENTAL CLINICIANS TO HIGHLIGHT TONGUE-TIE TREATMENT BEST PRACTICES
-
BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2022 RESULTS ON MARCH 28, 2023
-
BIOLASE PLANS TO LAUNCH SEASON 2 OF ITS POPULAR PODCAST SERIES
-
BIOLASE LAUNCHES E-COMMERCE SITE TO ENHANCE POSITIVE USER EXPERIENCE AND STREAMLINE THE PURCHASING PROCESS TO CREATE GREATER EFFICIENCIES FOR DENTAL PRACTITIONERS
-
BIOLASE ENTERS THE SKIN RESURFACING MARKET IN THE U.S. WITH THE LAUNCH OF A NEW WATERLASE FRACTIONAL HANDPIECE
-
BIOLASE FURTHER ENHANCES MARKET AWARENESS CAMPAIGN WITH THE MUCH ANTICIPATED LAUNCH OF NEW EDUCATION PORTAL
-
BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE
-
BIOLASE RECEIVES SECOND TOP WORKPLACES 2022 AWARD
-
Strateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands Team
-
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
-
BIOLASE REJECTS SONENDO'S "PATENTLY ABSURD" CLAIMS
-
BIOLASE MAINTAINS POSITIVE MOMENTUM THROUGH YEAR END WITH SOLID FOURTH QUARTER REVENUE GROWTH; SIGNIFICANT MARKET OPPORTUNITY AND INDUSTRY-LEADING PRODUCT SUPPORT EXPECTATION FOR ROBUST REVENUE GROWTH
-
BIOLASE RECEIVES TOP WORKPLACES 2022 AWARD
-
BIOLASE INC. ANNOUNCES PRICING OF APPROXIMATELY $9.75 MILLION UNDERWRITTEN PUBLIC OFFERING
-
BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York
-
BIOLASE DELIVERS 26% REVENUE GROWTH YEAR OVER YEAR IN THIRD QUARTER AND RAISES 2022 FULL YEAR REVENUE GUIDANCE
Back to BIOL Stock Lookup
